Literature DB >> 25034896

Reply: is nucleus accumbens atrophy correlated with cognitive symptoms of Parkinson's disease?

Oury Monchi1, Alexandru Hanganu2.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25034896      PMCID： PMC4441075          DOI： 10.1093/brain/awu200

Source DB:  PubMed          Journal:  Brain        ISSN： 0006-8950            Impact factor:   13.501


× No keyword cloud information.
  9 in total

1.  Apathy is associated with volume of the nucleus accumbens in patients infected with HIV.

Authors:  Robert H Paul; Adam M Brickman; Bradford Navia; Charles Hinkin; Paul F Malloy; Angela L Jefferson; Ronald A Cohen; David F Tate; Timothy P Flanigan
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2005       Impact factor: 2.198

2.  Lack of ventral striatal response to positive stimuli in depressed versus normal subjects.

Authors:  Jane Epstein; Hong Pan; James H Kocsis; Yihong Yang; Tracy Butler; Jesse Chusid; Hilary Hochberg; James Murrough; Erika Strohmayer; Emily Stern; David A Silbersweig
Journal:  Am J Psychiatry       Date:  2006-10       Impact factor: 18.112

3.  Dopamine in thelimbic regions of the human brain: normal and abnormal.

Authors:  I J Farley; K S Price; O Hornykiewicz
Journal:  Adv Biochem Psychopharmacol       Date:  1977

4.  Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson's disease longitudinally.

Authors:  Alexandru Hanganu; Christophe Bedetti; Clotilde Degroot; Béatriz Mejia-Constain; Anne-Louise Lafontaine; Valérie Soland; Sylvain Chouinard; Marie-Andrée Bruneau; Samira Mellah; Sylvie Belleville; Oury Monchi
Journal:  Brain       Date:  2014-03-10       Impact factor: 13.501

5.  The human nucleus accumbens suffers parkinsonism-related shrinkage: a novel finding.

Authors:  Ioannis Mavridis; Efstathios Boviatsis; Sophia Anagnostopoulou
Journal:  Surg Radiol Anat       Date:  2011-03-15       Impact factor: 1.246

6.  The effect of dopamine therapy on ventral and dorsal striatum-mediated cognition in Parkinson's disease: support from functional MRI.

Authors:  Penny A MacDonald; Alex A MacDonald; Ken N Seergobin; Ruzbeh Tamjeedi; Hooman Ganjavi; Jean-Sebastien Provost; Oury Monchi
Journal:  Brain       Date:  2011-05       Impact factor: 13.501

7.  Striatal morphology in early-onset and late-onset Alzheimer's disease: a preliminary study.

Authors:  Michela Pievani; Martina Bocchetta; Marina Boccardi; Enrica Cavedo; Matteo Bonetti; Paul M Thompson; Giovanni B Frisoni
Journal:  Neurobiol Aging       Date:  2013-02-19       Impact factor: 4.673

Review 8.  The nucleus accumbens: a target for deep brain stimulation in obsessive-compulsive- and anxiety-disorders.

Authors:  Volker Sturm; Doris Lenartz; Athanasios Koulousakis; Harald Treuer; Karl Herholz; Johannes Christian Klein; Joachim Klosterkötter
Journal:  J Chem Neuroanat       Date:  2003-12       Impact factor: 3.052

9.  The neuropsychiatric profile of Parkinson's disease subjects with and without mild cognitive impairment.

Authors:  Roberto Monastero; Paola Di Fiore; Giusi D Ventimiglia; Rosolino Camarda; Cecilia Camarda
Journal:  J Neural Transm (Vienna)       Date:  2013-02-12       Impact factor: 3.575
  9 in total
  1 in total

Review 1.  Structural Neuroimaging Markers of Cognitive Decline in Parkinson's Disease.

Authors:  Alexandru Hanganu; Oury Monchi
Journal:  Parkinsons Dis       Date:  2016-04-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.